1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SDC3 CTRPv2 pan-cancer AAC 0.18 0.0002
mRNA NFATC2 CTRPv2 pan-cancer AAC 0.16 0.0002
mRNA TAS2R41 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA CYR61 CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA ATXN2 CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA ABCD1 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA TSNAX-DISC1 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA SMAGP CTRPv2 pan-cancer AAC 0.16 0.0002
mRNA DNAJA4 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA GPR75-ASB3 CTRPv2 pan-cancer AAC -0.14 0.0002
Download CSV